IDH1 and neoplasm: There is support that hypermethylation of DNA damage pathways is unique to the IDH1 R132Q mutant; H3 histone hypermethylation studies with in vivo IDH1 R132H-expressing tumor models have suggested up-regulation of DNA damage response and cell cycle control (75).